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Experimental design, first developed by Sir Ronald A. Fisher (1 ) , is a structured, organized method for determining the relationship between the different factors affecting an experimental process and the output of that process. The use of quantitative PCR (qPCR) 6 to study gene expression (2-6 ) requires statistical considerations of all invoked factors: the treatment effect, the intersubject biological variance, and the noise due to sample processing. In addition, the gene-specific effect on the error structure must be considered. A typical qPCR experiment designed to test a hypothesis that a difference in gene expression exists between groups of biological subjects exposed to different treatments involves sampling the biological material, extracting the RNA, reverse transcription (RT) of the RNA into cDNA, and amplification of the cDNA by the qPCR. Too often, experiments are designed and conducted with excessive emphasis on the amplification step while ignoring the preceding steps and their contribution to the measurement error.
The measured difference between any 2 groups has 3 contributions: the treatment effect, intersubject variation, and processing noise (Table 1) . Exact definitions for these variance contributions, as well as the models for their calculation, are given in Supplemental Text 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/ content/vol55/issue10. The relationship between the effect, variation, and the number of subjects studied can be calculated with the power test, which is exemplified in Fig. 2 in the online Data Supplement.
In general, independent errors are additive. Fluctuations in yield due to pipetting errors, uncertainties in instrument readings, and chemical noise in the different processing steps are expected to be independent. Interference due to inhibitors is not independent, however, because any inhibiting substance present in a sample will propagate through the subsequent processing steps of that sample, although the inhibitor will gradually be removed and diluted. The noise observed for a given processing step is only partially attributable to that step, because it also accommodates the noise from any previous step(s) performed after the compared samples were separated. For example, the qPCR noise as measured by the SD () reflects not only that of the qPCR but also the RT noise if the replicate samples were separated before the RT step. To objectively assess the contribution of individual processing steps to the overall noise requires a model that reflects the additive noise structure.
An experiment that studies gene expression with real-time PCR has a nested (i.e., hierarchical or clustered) structure (7, 8 ) , meaning that the qPCR is run on individual RT products, mRNAs are obtained from samples, samples are collected from subjects (e.g., experimental animals), and subjects are selected from experimental groups (Fig. 1) . The nested design is justified because the same qPCR replicate cannot be dispensed from 2 different RT tubes, just as a single sample cannot be obtained from 2 different subjects. The nested design is a refinement of the factorial design that exploits the special character of the variance structure. In a factorial design, each factor is crossed with all The confounding variance consists of the intersubject variance and the processing variance. To maximize the resolution of the effect, the confounding variance must be substantially lower than the effect.
Fig. 1. Comparison of 3 groups with a nested experimental design.
Each group consists of 3 subjects, from which 3 samples are collected and extracted. The extracted and then split into 3 RT reactions, which are then finally into 3 qPCRs. The nested design is 3 ϫ 3 ϫ 3 ϫ 3 ϫ 3 and produces a total of 81 Cq values.
qPCR Design and Optimization others, whereas in the nested design, factors meet in unique combinations; there are no homogeneous replicates in the whole experiment, but rather clusters of replicates representing the integrated effects of the upstream processes.
The linear model of all hierarchical sampleprocessing effects within a single treatment group can be written as follows:
where Cq ijkl is the individual qPCR response, typically expressed as the number of amplification cycles required to reach a threshold fluorescence level; it incorporates the random effects of the ith subject, the jth sample, the kth RT, and the lth qPCR. is the total mean of the group expressed in the same unit of measure as Cq ijkl ; a i is the random effect of the ith subject; b j(i) is the random effect of the jth sample taken from subject i; c k(ij) is the random effect of the kth RT reaction from sample j of subject i; and d l(ijk) is the random effect of the lth qPCR from the kth cDNA of sample j from subject i.
In this model, all factors are randomly invoked. This feature requires the random selection of subjects, the collection of random samples and extraction of the RNA from each sample, the random dispensing of the RNA into the RT reactions, and the random dispensing of the cDNAs into the qPCR. In most experiments, the noise associated with the collection of a sample also encompasses the extraction noise, because 1 sample is typically acquired for 1 extraction.
The linear equation describing multiple groups with hierarchical replicates follows from Eq. 1:
where g indexes the experimental groups.
The model defined in Eq. 2 facilitates the comparison of various levels of factor g (the treatment effect).
The optimal experimental design requires knowing the sources of error throughout sample processing. To address this question, we performed several RTqPCR assays arranged in a nested hierarchy for different biological materials.
Materials and Methods
We studied 4 different kinds of samples: liver tissue from slaughtered heifers, blood from heifers, cultures of adherent, growing IPI-2I cells from porcine ileum, and individual astrocytes (single cells) from mouse brain (9 ) . For tissue, blood, and cell culture samples, we reverse-transcribed 500 ng of total RNA and amplified the cDNA by the qPCR, whereas for single cells we reverse-transcribed all of the RNA. Protocols and technical details are provided in Supplemental Texts 2 and 3 in the online Data Supplement.
STATISTICAL ANALYSIS
Variance analysis was performed with the PROC NESTED program in SAS software (version 9.1 for Microsoft Windows) with the model defined in Eq. 1 and according to the procedure outlined in Supplemental Text 1. We estimated variance contributions of the processing steps and the total variance as follows:
Variance contributions are expressed as:
where
The SD () is defined in this report with a superscript indicating the sample type and a subscript indicating the processing step. For example, Sampling Solid tissue is the estimated SD of the sampling step for solid tissue.
Results
All assays showed linearity over the entire range of Cq (cycle of quantification) values with efficiencies of 85%-100% (see Fig. 2 in the online Data Supplement).
SOLID TISSUE
We collected 3 liver samples from each of 3 slaughtered heifers and extracted the RNA. Each extract was split into 3 aliquots for RT, each of which was split again into 3 qPCR aliquots. These aliquots were analyzed for 4 genes: ACTB 7 (actin, beta), IL1B (interleukin 1, beta), CASP3 (caspase 3, apoptosis-related cysteine peptidase), and FGF7 [fibroblast growth factor 7 (keratinocyte growth factor)] in singleplex format. Hence, we used a nested design (3 subjects ϫ 3 samples ϫ 3 RTs ϫ 3 qPCRs) that yielded 81 Cq values for each of the 4 genes. Estimated SDs ( 's) for the various processing levels are shown in Table 2 . Also shown is the cumulative variation, which is expressed as the SD of measured Cq values ( Cq Solid tissue ) obtained from different animals (as if they were processed independently without technical replicates). ACTB, IL1B, and CASP3 had Cqs of Ͻ28 cycles, whereas FGF7 had low expression (mean Cq, 31.5 cycles). The largest SD was estimated for the sampling step, with Sampling
Solid tissue values of 1.20 -1.64 cycles for the first 3 genes and a Sampling Solid tissue value of 0.40 cycles for FGF7. The mean was 1.20 cycles. This value corresponds to a Ͼ2-fold variation in sampling yield, which most likely reflects sample heterogeneity. RT Solid tissue for the first 3 genes was 0.27-0.46 cycles (mean, 0.39 cycles), and the FGF7 RT Solid tissue was 0.90 cycles. The qPCR step showed the highest reproducibility, with qPCR Solid tissue values of 0.07-0.12 cycles (mean, 0.09 cycles) for the first 3 genes and 0.39 cycles for FGF7. It was not possible to estimate Subjects Solid tissue because its contribution to the overall noise was too small compared with the contributions of the subsequent steps. Cq
Solid tissue values were 1.06 -1.70 cycles. Expressed as variance contributions (Eq. 4), sampling accounted for Ͼ90% of the total variance for the first 3 genes (Fig. 2) , whereas the contribution of sampling to total variance for the low-expressed FGF7 gene was Ͻ20%.
BLOOD
One blood sample was collected from each of 3 heifers. Lysed cells from the blood samples were split into 3 vials for RNA extractions. Each extract was then split into 3 RT reactions, and each cDNA product was analyzed in 3 qPCR replicates for each of 4 genes [ACTB, CASP3, IL1B, and IFNG (interferon, gamma)]. In total, 81 Cq values were measured with the nested design for each of the 4 genes (3 subjects ϫ 1 sample ϫ 3 extractions ϫ 3 RTs ϫ 3 qPCRs We disseminated 6 ϫ 10 4 adherent, growing IPI-2I cells from porcine ileum in 10 wells, from which we extracted total RNA. Each RNA sample was reversetranscribed in 3 reactions, each of which was divided into 3 qPCR replicates for each of 4 genes [BCL2 (B-cell CLL/lymphoma 2), ACTB, H3F3A (histone H3
Cell culture (mean, 0.27 cycles) (Fig. 2) . Because each sample was extracted without replicates, Sampling
Cell culture reflects the combined noise introduced by the growing of the samples and their subsequent extraction. Expressed as noise contributions, the sampling and RT steps each accounted for at least 30% of the variation, and the qPCR step accounted for Ͼ25% (Table 2) .
SINGLE CELLS
Three astrocytes were collected from each of 3 mice, lysed, and split into 3 replicates for RT. These replicates were then split into another 3 replicates for qPCR assays for 18S rRNA (Rn18s, 18S RNA). The experimental design was as follows: 3 subjects ϫ 3 samples ϫ 1 extraction ϫ 3 RTs ϫ 3 qPCRs. The estimated SDs were 0.51 cycles for qPCR Single cell value is consistent with previous findings that mRNA concentrations in cells show lognormal variation (10 ) . Subjects Single cell was negligible, and Cq Single cell was 1.99 cycles. Our inspection of the variance contributions revealed that heterogeneity among the cells totally dominated the overall error, with a contribution of Ͼ90%.
Discussion

INDIVIDUAL CELLS AND SOLID TISSUE SHOW THE HIGHEST
VARIATION
Confounding biological variation and analytical noise in a qPCR assay limits the ability to observe differential expression of treatment groups. The total variance, including biological variation and experimental noise, is given by Eq. 3 and is denoted as Cq 2 . The greatest variation is between individual cells and is equivalent to the normal distribution of Cq values. Thus, 68% of the cells in the population are expected to have an expression within the mean Ϯ 1 SD. Given the mean Cq of 18S mRNA in single astrocytes (Table 2) , taking into account the dilutions that were performed, and assuming extraction and RT yields of 100% and a PCR assay efficiency of 90% (11-12 ) , we estimate the mean number of copies per cell to be on the order of 10 000. Hence, 16% [(100 Ϫ 68)/2] of the cells should have Ͻ2500 copies/cell (10 000/8), and 16% should have Ͼ40 000 copies/cell. This large observed variation is consistent with previously published findings (13) (14) (15) (16) .
Our analysis also revealed substantial variation for solid tissue, with a mean Cq Solid tissue of 1.40 cycles, which corresponds to variation of 2.6-fold (i.e., 2 1.4 ). Cq values obtained with samples of solid tissues are commonly assumed to be normally distributed, but to our knowledge, the validity of this assumption has yet to be demonstrated. Because the variance is dominated by the sampling step, whether Cq values are normally distributed may depend on the complexity of the tissue, as well as on the size of the excised sample. It may also be gene dependent. For the low-expressed FGF7 gene, the majority of the overall noise was introduced at the RT step. The reason for this result is unknown, and with only a single case, we cannot be sure about the significance of the observation. One possibility is that it may be due to the lower abundance of FGF7 mRNA in the liver tissue, perhaps combined with a more homogeneous distribution of FGF7-expressing cells. Because the same amount of total RNA was processed in all samples, the data are inherently normalized to total RNA. Hence, sampling variation reflects heterogeneity in the distribution of the targeted mRNA relative to that of total RNA in the tissue and is not due, for example, to different quantities of material processed.
In the blood samples, 2 genes had Cq Blood values of 0.25 and 0.31 cycles, and the other 2 genes had Cq Blood values of approximately 1 cycle. This result is because the first 2 genes had only the variance contributed from the RT and qPCR steps, whereas the intersubject variance was substantial for the other 2 genes. This finding suggests that the spread in measured Cq values can have different origins, depending on the gene, even when the same subjects and tissue are analyzed (17 ) . The noise arising from sampling and extraction was consistently small across all of the studied genes, indicating that this step is very reproducible for blood samples.
The lowest overall confounding variation was found for the cell culture samples, which had a mean Cq Cell culture value of 0.43 cycles.
USE OF qPCR REPLICATES HAS LITTLE JUSTIFICATION
The total confounding variance, Cq , can be reduced not only by increasing the number of subjects but also by performing technical replicates to "average out" processing noise. The effect of technical replicates depends on both the noise contributed by that particular step and the noise contributed by subsequent steps. The final step in RT-qPCR process is the qPCR. Many published reports have described the use of experimental protocols that perform only qPCR replicates. On the basis of the variance contributions we have estimated for the 4 studied sample types, we are able to evaluate the importance of qPCR replicates. For 10 of 13 measurements, we find qPCR values of 0.07-0.21 cycles, with a mean of 0.13 cycles. Clearly, qPCR does not depend on sample type, a reasonable finding given that the preceding steps should have removed substances that interfere with the PCR. The mean qPCR of 0.13 cycles is similar to previous findings (11 ) . The 3 higher qPCR values are for the low-expressed genes FGF7 in liver and IFNG in blood, and for 18S rRNA in the individual astrocytes. Low amounts of cDNA template are expected to give data with greater noise because of a Poisson-distributed sampling error and the replication noise introduced during early PCR cycles. A practical threshold of approximately 25 copies per reaction has been suggested. We conclude that a qPCR value of 0.13 cycles is a good estimate for genes that are expressed at reasonable levels and are assayed with a protocol that yields at least some 25 template copies per qPCR.
The noise introduced by the RT appears to be consistent and small for samples of all types ( RT , 0.18 -0.90 cycles; mean, 0.35 cycles). This estimate of RT should be reasonable and suggests that the reproducibility of the RT step is approximately 2 times less than that of the qPCR, as has also previously been reported (11) (12) .
The noise introduced by sampling depends on the specimen. The mean Sampling was 1.9 cycles for single cells, 1.20 cycles for liver tissue, 0.27 cycles for cell culture, and 0.05 cycles for blood. Compared with the imprecision of the RT and qPCR steps, sampling of single cells and liver tissue shows far greater variation than the RT-qPCR, whereas for cell culture, sampling contributes noise that is comparable to that of the RT. Sampling blood shows negligible variation.
Intersubject variation, which represents the biological variation among inbred heifers and mice in this study, has been difficult to estimate. It is the top level of the nested design, and its contribution is therefore confounded by the contributions from the processing steps that follow. Therefore, this source of the variance cannot be estimated with reasonable precision unless it dominates. For the liver samples and single cells, estimation of intersubject variation failed. Very little intersubject biological variation occurred in the cell culture samples because only a single clone was studied. We were able to estimate Subject only for the blood samples. For ACTB and CASP3, Subjects Blood was negligible, whereas it was approximately 1 cycle for IL1B and IFNG. For the latter 2 genes, Subjects Blood made the dominant contribution, accounting for Ͼ80% of the total variance. This result indicates that intersubject noise may be gene dependent, although more data are needed to substantiate this conclusion.
qPCR was performed in duplicate in most published studies, although performing such replicates has usually not been justified. According to our estimates of the noise contributions of the sample-processing steps, qPCR is consistently lower than the noise contributions of most of the other steps. The highest estimated contribution of qPCR to the total variance was 36% for ACTB in blood; however, this value is abnormal and may be accidental owing to low contributions from the other steps in this particular experiment. The mean variance contribution from the qPCR step was only 11%. Because neither qPCR nor RT shows any dependence on the gene and sample studied and because RT is 2 times higher than qPCR , the noise contributed by the qPCR should always be smaller than that contributed by the RT and other steps.
The noise contributed by any step in the processing of a sample can be reduced by performing replicates and by use of mean values in subsequent analyses. The SD of a mean is the SE, which for an isolated processing step is:
Performing a qPCR in duplicate reduces its noise contribution from 0.13 cycles to:
SE qPCR ϭ qPCR /ͱ2 ϭ qPCR ϫ 0.7 Х 0.09 cycles.
This reduction is not a substantial improvement, compared with the total processing noise. One can imagine that qPCR replicates might substantially reduce the total variance when the amount of cDNA template is very low (18 ) . This strategy is not valid in practice, however. If the amount of cDNA is indeed limiting, it is preferable to keep all of the material in a single sample and analyze it in a single run than to split it into duplicates that are analyzed separately and averaged. This is because the splitting process further reduces the already low number of cDNA copies per sample and thereby increases the noise. When many genes are assayed, splitting samples and the subsequent reduction in the number of cDNA copies may be unavoidable. The preferred strategy in this situation is first to preamplify the cDNA in a multiplex reaction to increase the number of all cDNAs and then to split the reaction into aliquots for singleplex analyses of the individual genes. This strategy avoids the introduction of severe noise at low template copy numbers. Thus, there is really no situation in which splitting qPCRs into technical replicates is justifiable from a dataquality perspective. The only reason to run replicate qPCRs is to insure against a failed reaction so that the data point is not missed. But this consideration is relevant only if no upstream technical replicates are available, because they too provide this redundancy.
The decision of where to produce replicates and how many to use is often a compromise between attaining the maximum accuracy and performing the experiments within a specified budget. If costs are known for the subject, sample, RT, and qPCR steps, the optimal sampling plan can be calculated as follows:
where ʲ Cq 2 is the variance of the mean Cq and n x is the number of replicates at step x. Various combinations of n x can be created, and the one that minimizes ʲ Cq 2 in Eq. 7 and does not exceed the specified budget is chosen as the "cost-optimal" plan ( Table 3) . General recommendations for experimental setup are given in Table 1 in the online Data Supplement. A software tool can be requested from the corresponding author or downloaded (http://www.powernest.net).
NORMALIZATION WITH CONTROLS DOES NOT NECESSARILY IMPROVE DATA QUALITY
A common approach to reduce confounding variation is to use controls, most commonly endogenous reference genes. Normalizing with a control gene corresponds to calculating the difference between the Cqs of the gene of interest (GOI) and the reference gene (Ref):
The purpose of normalization is to reduce the SD of ⌬Cq relative to that of Cq GOI (i.e., for successful normalization, ⌬Cq Ͻ Cq ). This is by no means an expected result. The SD of ⌬Cq is:
where Ref/GOI 2 is the covariance between the Cqs of the GOI and the reference gene. If the covariance is smaller than the variance of the GOI and the reference gene each, normalization will actually increase the confounding noise. The covariance is a measure of how the preprocessing steps are affecting the GOI and the reference gene relative to each other. If the noise introduced in the preprocessing steps always affects the GOI and the reference gene in the same way (i.e., both are always processed in either high or low yield), then the covariance is high. If the noise affects them independently, however, normalization is meaningless; in fact, it even worsens the quality of the data (Table 4 ). With respect to the genes we have analyzed, the SD increases with normalization for IFNG in liver and for CASP3 in blood. ) than the 3 ϫ 1 ϫ 3 ϫ 1 design, despite the major source of noise being the RT step. This analysis shows that a design that incorporates upstream replicates is superior to one that incorporates replicates at subsequent processing steps. 
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